{
  "company": {
    "name": "Nephrogen",
    "website": "https://nephrogenbiotech.com/",
    "record": "https://startuphistory.org/c/nephrogenbiotech.com"
  },
  "status": null,
  "history_since": "2016-02-04T09:28:29.000Z",
  "baseline": {
    "snapshot_id": "bc8bdc24262f3c70d660f76e6275e2f86ddc2516a629e7da5ea8c9bbda276a33",
    "observed_at": "2017-06-03T03:48:26.000Z",
    "headline": "Nephrogen - Home",
    "description": "Nephrogen is a research-stage biotechnology company founded in August 2015 dedicated to developing novel therapeutics and medical devices for patients suffering from kidney disease and kidney failure.",
    "evidence": "https://web.archive.org/web/20170603034826/http://www.nephrogenbiotech.com:80/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:47:03.732Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2018-01-28T15:48:38.000Z",
      "variants": [
        {
          "headline": "Nephrogen - Home",
          "subhead": "Nephrogen is a research-stage biotechnology company founded in August 2015 dedicated to developing novel therapeutics and medical devices for patients suffering from kidney disease and kidney failure.",
          "observed_at": "2017-06-03T03:48:26.000Z",
          "evidence": "https://web.archive.org/web/20170603034826/http://www.nephrogenbiotech.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Nephrogen - Home",
          "subhead": "Nephrogen is a research-stage biotechnology company founded in August 2015 dedicated to developing novel therapeutics and medical devices for patients suffering from kidney disease and kidney failure.",
          "observed_at": "2018-01-28T15:48:38.000Z",
          "evidence": "https://web.archive.org/web/20180128154838/http://www.nephrogenbiotech.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Nephrogen - Home",
      "subhead": "Nephrogen is a research-stage biotechnology company founded in August 2015 dedicated to developing novel therapeutics and medical devices for patients suffering from kidney disease and kidney failure.",
      "from": "2017-06-03T03:48:26.000Z",
      "to": "2018-01-28T15:48:38.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20180128154838/http://www.nephrogenbiotech.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2017-06-03T03:48:26.000Z",
          "to": "2018-01-28T15:48:38.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:47:03.732Z",
      "variants": [
        {
          "headline": "We're building next generation solutions for life threatening kidney diseases.",
          "subhead": "Nephrogen is a therapeutics company developing transformative medicines for kidney disease. Our initial focus is on gene therapy for autosomal dominant polycystic kidney disease (ADPKD).",
          "observed_at": "2021-06-04T19:07:33.000Z",
          "evidence": "https://web.archive.org/web/20210604190733/https://www.nephrogenbiotech.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We're building next generation solutions for life threatening kidney diseases.",
          "subhead": "Nephrogen is a therapeutics company developing transformative medicines for kidney disease. Our initial focus is on gene therapy for autosomal dominant polycystic kidney disease (ADPKD).",
          "observed_at": "2022-08-11T02:59:54.000Z",
          "evidence": "https://web.archive.org/web/20220811025954/https://www.nephrogenbiotech.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We're building curative gene therapies for life threatening kidney diseases.",
          "subhead": "Nephrogen is a therapeutics company developing transformative medicines for kidney disease. Our initial focus is on gene therapy for autosomal dominant polycystic kidney disease (ADPKD).",
          "observed_at": "2023-09-26T18:34:00.000Z",
          "evidence": "https://web.archive.org/web/20230926183400/https://www.nephrogenbiotech.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We're building curative gene therapies for life threatening kidney diseases.",
          "subhead": "Nephrogen is a therapeutics company developing transformative medicines for kidney disease. Our initial focus is on gene therapy for autosomal dominant polycystic kidney disease (ADPKD).",
          "observed_at": "2024-07-25T13:45:03.000Z",
          "evidence": "https://web.archive.org/web/20240725134503/https://www.nephrogenbiotech.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We're building curative genomic medicines for kidney and pancreatic diseases.",
          "subhead": "Nephrogen is a preclinical biotech company developing curative genomic medicines for serious diseases. Our initial focus is on kidney and pancreatic diseases.",
          "observed_at": "2025-10-26T02:33:11.000Z",
          "evidence": "https://web.archive.org/web/20251026023311/https://www.nephrogenbiotech.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We're building curative genetic medicines for kidney and pancreatic diseases.",
          "subhead": "Nephrogen is a preclinical biotech company developing curative genomic medicines for serious diseases. Our initial focus is on kidney and pancreatic diseases.",
          "observed_at": "2026-07-11T06:00:14.000Z",
          "evidence": "https://web.archive.org/web/20260711060014/https://www.nephrogenbiotech.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We're building curative genetic medicines for kidney and pancreatic diseases.",
          "subhead": "Nephrogen is a preclinical biotech company developing curative genomic medicines for serious diseases. Our initial focus is on kidney and pancreatic diseases.",
          "observed_at": "2026-11-06T17:47:03.732Z",
          "evidence": "https://www.nephrogenbiotech.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "We're building curative genetic medicines for kidney and pancreatic diseases.",
      "subhead": "Nephrogen is a preclinical biotech company developing curative genomic medicines for serious diseases. Our initial focus is on kidney and pancreatic diseases.",
      "from": "2021-06-04T19:07:33.000Z",
      "to": "2026-11-06T17:47:03.732Z",
      "captures": 7,
      "evidence": "https://www.nephrogenbiotech.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2021-06-04T19:07:33.000Z",
          "to": "2026-11-06T17:47:03.732Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-a3bc3103ea8d374337e8096eb6ad63d39bd8e035e8f0e8b644b557d1c5df13ac:642916a430c68634c5b0db36313bc9803b08837713ac14f20cfd9253c87f88a6:compliance:9337a1fa8f602109",
      "before_evidence": "https://web.archive.org/web/20180128154838/http://www.nephrogenbiotech.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "compliance",
      "label": "Compliance",
      "summary": "Now states FDA APPROVED compliance on its homepage.",
      "between": {
        "from": "2018-01-28T15:48:38.000Z",
        "to": "2021-06-04T19:07:33.000Z"
      },
      "evidence": "https://web.archive.org/web/20210604190733/https://www.nephrogenbiotech.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-compliance"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Nephrogen” company record, https://startuphistory.org/c/nephrogenbiotech.com"
}